EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru

Nawal De la Peña Galindo, Silvia Capristano Valdez, Cesar Sanchez Neira, Henri Bailon Calderon, Gilmer Solis Sanchez, Flor Peceros Pelaez, Marco Galarza Perez iD

Pathogens · 2025

DOI: 10.3390/pathogens14121225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Nawal De la Peña Galindo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru. Hauptthemen laut MEDLINE: Chemokine CXCL10, Latent Tuberculosis, Interleukin-5. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica, PROCIENCIA-CONCYTEC-Peru, Instituto Nacional de Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peru ranks among the countries with the highest burden of tuberculosis in Latin America. Interferon Gamma Release Assays (IGRAs), such as QuantiFERON-TB (QFT), cannot distinguish latent tuberculosis infection (LTBI) from active tuberculosis (ATB), but they provide a more specific and quantitative assessment of prior exposure to Mycobacterium tuberculosis.

Methods

We enrolled 56 participants and measured 38 cytokines/chemokines from plasma obtained through QFT in patients with active TB (n = 11), LTBI (n = 17), and QFT-negative healthy controls (n = 28) using a Multiplex Bead Assay.

Results

Levels of IL-1RA, IL-2, IL-5, IFN-γ, and IP-10 significantly differentiated both ATB and LTBI groups from healthy controls (p < 0.035). Furthermore, IL-5 and IP-10 specifically distinguished LTBI from healthy controls (p < 0.015), while GM-CSF differentiated ATB from controls (p < 0.05).

Conclusions

Beyond IFN-γ as a differential proinflammatory cytokine in TB, cytokines such as IL-5, and IP-10 show potential as biomarkers to discriminate infection status in high-burden TB settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL10Latent TuberculosisInterleukin-5HumansPeruMaleFemaleAdultMiddle AgedInterferon-gamma Release TestsMycobacterium tuberculosisYoung AdultBiomarkersInterferon-gammaAdolescent

Stichwörter der Autor:innen

IGRAschemokinescytokineslatent tuberculosis

Substanzen

Chemokine CXCL10Interleukin-5CXCL10 protein, humanIL5 protein, humanBiomarkersInterferon-gamma

Autor:innen und Institutionen

  • Innovation and Development Area, Instituto Nacional de Salud, Lima 15046, Peru.
  • Health Technology Assessment Center, Instituto Nacional de Salud, Lima 15046, Peru.
  • Virology Unit, Instituto Nacional de Salud, Lima 15046, Peru.

ORCID-Profile: Marco Galarza Perez

Förderung

  • Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
  • PROCIENCIA-CONCYTEC-Peru
  • Instituto Nacional de Salud

Zitieren

APA

De la Peña Galindo, N., Valdez, S. C., Neira, C. S., Calderon, H. B., Sanchez, G. S., Pelaez, F. P., & Galarza Perez, M. (2025). IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru. Pathogens. https://doi.org/10.3390/pathogens14121225

Vancouver

De la Peña Galindo N, Valdez SC, Neira CS, Calderon HB, Sanchez GS, Pelaez FP, et al. IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru. Pathogens. 2025. doi:10.3390/pathogens14121225

BibTeX
@article{DelaPeaGalindo2025,
  author = {De la Peña Galindo, Nawal and Valdez, Silvia Capristano and Neira, Cesar Sanchez and Calderon, Henri Bailon and Sanchez, Gilmer Solis and Pelaez, Flor Peceros and Galarza Perez, Marco},
  title = {IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, Peru},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14121225}
}
Kostenlos starten →